Valuation: 10x Genomics, Inc.

Market Cap 5.55B 4.85B 4.48B 4.13B 7.78B 535B 7.95B 53.52B 21.05B 262B 20.85B 20.4B 902B P/E 2026 *
-53.9x
P/E 2027 * -62.6x
Enterprise Value 5.07B 4.43B 4.09B 3.77B 7.11B 489B 7.27B 48.91B 19.24B 239B 19.06B 18.64B 824B EV / Sales 2026 *
8.26x
EV / Sales 2027 * 7.45x
Free-Float
90.53%
Yield 2026 *
-
Yield 2027 * -
1 day-1.66%
1 week+2.36%
Current month+14.08%
1 month+36.13%
3 months+67.71%
6 months+113.16%
Current year+168.18%
1 week 41.6
Extreme 41.6
46.32
1 month 31.3
Extreme 31.3
46.32
Current year 15.9
Extreme 15.9
46.32
1 year 11.16
Extreme 11.16
46.32
3 years 6.78
Extreme 6.78
63.57
5 years 6.78
Extreme 6.78
191.15
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 2012-07-01
President 51 2012-09-30
Director of Finance/CFO 51 2024-08-11
Director TitleAgeSince
Director/Board Member 51 2012-07-01
Director/Board Member 49 2012-07-01
Chairman 68 2013-07-31
Date Insider Type Main position Quantity % Market Cap.
6/22/26 Sell

Founder

-30,000 0.0257%
6/16/26 Sell

Director

-5,723 0.0049%
6/4/26 Free

Director

8,829 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
-1.66%+2.36%+251.33%-25.86% 5.55B
+0.56%-2.61%+229.67%+311.59% 20.67B
+0.41%+4.58%-38.29%-21.77% 9.85B
+2.36%+1.85%+46.18%+23.10% 7B
+0.36%+3.63%-16.92%-28.57% 5.23B
+0.06%-2.94%-47.29% - 4.66B
+10.00%+34.69%+106.09%+132.05% 4.9B
-0.66%+0.73%-23.15%-24.82% 4.2B
-2.66%+4.71%-15.30%-40.67% 2.72B
-11.01%+2.37%-36.38%+212.50% 1.65B
Average -0.22%+5.89%+45.59%+59.73% 6.64B
Weighted average by Cap. +0.69%+3.74%+91.81%+111.31%

Financials

2026 *2027 *
Net sales 614M 537M 495M 456M 860M 59.14B 879M 5.92B 2.33B 28.96B 2.31B 2.26B 99.7B 671M 587M 541M 499M 941M 64.66B 962M 6.47B 2.55B 31.67B 2.52B 2.47B 109B
Net income -104M -91.29M -84.24M -77.65M -146M -10.06B -150M -1.01B -396M -4.93B -392M -384M -16.96B -90.68M -79.25M -73.13M -67.41M -127M -8.73B -130M -874M -344M -4.28B -341M -333M -14.72B
Net Debt -478M -418M -386M -356M -670M -46.06B -685M -4.61B -1.81B -22.56B -1.8B -1.76B -77.66B -548M -479M -442M -407M -768M -52.78B -785M -5.28B -2.08B -25.85B -2.06B -2.01B -88.98B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Employees
1,178
Date Price Change Volume
26-07-17 US$43.74 -1.66% 2,567,096
26-07-16 US$44.48 -2.78% 4,717,082
26-07-15 US$45.75 -0.09% 4,747,102
26-07-14 US$45.79 +9.62% 3,835,839
26-07-13 US$41.77 -2.25% 2,497,014
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
43.74USD
Average target price
39.85USD
Spread / Average Target
-8.90%

Quarterly revenue - Rate of surprise